Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture
Osteogenic actions of the anti-diabetic drug metformin on osteoblasts in culture
复制标题
DOI:
10.1016/j.ejphar.2006.02.030
复制
发表时间:
2006-04-24
影响因子:
5
通讯作者:
Schurman, L
中科院分区:
文献类型:
--
作者:
Cortizo, AM;Sedlinsky, C;Schurman, L
An association has been previously established between uncompensated diabetes mellitus and the loss of bone mineral density and/or quality. In this study, we evaluated the effects of metformin on the growth and differentiation of osteoblasts in culture Treatment of two osteoblast-like cells (UMR106 and MC3T3E1) with metformin (25-500 mu M) for 24h led to a dose-dependent increase of cell proliferation. Metformin also promoted osteoblastic differentiation: it increased type-I collagen production in both cell lines and stimulated alkaline phosphatase activity in MC3T31 osteoblasts. In addition, metformin markedly increased the formation of nodules of mineralization in 3-week MC3T3E1 cultures. Metformin induced activation and redistribution of phosphorylated extracellular signal-regulated kinase (P-ERK) in a transient manner, and dose-dependently stimulated the expression of endothelial and inducible nitric oxide synthases (e/iNOS). These results show for the first time a direct osteogenic effect of metformin on osteoblasts in culture, which could be mediated by activation/redistribution of ERK-1/2 and induction of e/ NOS.(c) 2006 Elsevier B.V All rights reserved.